Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
REVENUES:        
Product revenue $ 4,050 $ 0 $ 4,050 $ 0
Total revenues 4,050 0 4,050 0
Product and other costs 701 0 701 0
Total cost of goods sold 701 0 701 0
GROSS MARGIN 3,349 0 3,349 0
COSTS AND EXPENSES:        
General and Administrative 1,385,102 1,629,553 2,953,478 2,976,295
Research and Development 442,113 438,048 843,910 1,117,821
Total costs and expenses 1,827,215 2,067,601 3,797,388 4,094,116
LOSS FROM OPERATIONS (1,823,866) (2,067,601) (3,794,039) (4,094,116)
OTHER EXPENSE:        
Interest expense 31,793 4,238 34,762 6,043
Amortization of debt discount   0 214,913 0
Total other expense 246,706 4,238 249,675 6,043
NET LOSS $ (2,070,572) $ (2,071,839) $ (4,043,714) $ (4,100,159)
BASIC AND DILUTED LOSS PER SHARE $ (0.22) $ (0.22) $ (0.43) $ (0.44)
WEIGHTED AVERAGE BASIC AND DILUTED SHARES OUTSTANDING 9,419,660 9,419,660 9,419,660 9,419,660